» Articles » PMID: 19409634

Convergence of Biomarkers, Bioinformatics and Nanotechnology for Individualized Cancer Treatment

Overview
Specialty Biochemistry
Date 2009 May 5
PMID 19409634
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in biomarker discovery, biocomputing and nanotechnology have raised new opportunities in the emerging fields of personalized medicine (in which disease detection, diagnosis and therapy are tailored to each individual's molecular profile) and predictive medicine (in which genetic and molecular information is used to predict disease development, progression and clinical outcome). Here, we discuss advanced biocomputing tools for cancer biomarker discovery and multiplexed nanoparticle probes for cancer biomarker profiling, in addition to the prospects for and challenges involved in correlating biomolecular signatures with clinical outcome. This bio-nano-info convergence holds great promise for molecular diagnosis and individualized therapy of cancer and other human diseases.

Citing Articles

Advancements in Biotechnology and Stem Cell Therapies for Breast Cancer Patients.

Dhoundiyal S, Alam M Curr Stem Cell Res Ther. 2023; 19(8):1072-1083.

PMID: 37815191 DOI: 10.2174/011574888X268109230924233850.


A Review of the Nucleic Acid-Based Lateral Flow Assay for Detection of Breast Cancer from Circulating Biomarkers at a Point-of-Care in Low Income Countries.

Dyan B, Seele P, Skepu A, Mdluli P, Mosebi S, Sibuyi N Diagnostics (Basel). 2022; 12(8).

PMID: 36010323 PMC: 9406634. DOI: 10.3390/diagnostics12081973.


Tumor-Derived Lactate Creates a Favorable Niche for Tumor Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment.

Jin M, Cao W, Chen B, Xiong M, Cao G Front Cell Dev Biol. 2022; 10:808859.

PMID: 35646923 PMC: 9136137. DOI: 10.3389/fcell.2022.808859.


Fenton/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy.

Cao W, Jin M, Yang K, Chen B, Xiong M, Li X J Nanobiotechnology. 2021; 19(1):325.

PMID: 34656118 PMC: 8520258. DOI: 10.1186/s12951-021-01074-1.


Evaluation of Important Molecular Pathways and Candidate Diagnostic Biomarkers of Noninvasive to Invasive Stages in Gastric Cancer by In Silico Analysis.

Tutunchi S, Akhavan S, Bereimipour A, Ghaderian S J Oncol. 2021; 2021:5571413.

PMID: 34054953 PMC: 8131151. DOI: 10.1155/2021/5571413.


References
1.
Rehrauer H, Zoller S, Schlapbach R . MAGMA: analysis of two-channel microarrays made easy. Nucleic Acids Res. 2007; 35(Web Server issue):W86-90. PMC: 1933123. DOI: 10.1093/nar/gkm302. View

2.
Marquez D, Pietras R . Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 2001; 20(39):5420-30. DOI: 10.1038/sj.onc.1204729. View

3.
Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M . Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000; 406(6795):536-40. DOI: 10.1038/35020115. View

4.
Xing Y, Smith A, Agrawal A, Ruan G, Nie S . Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots. Int J Nanomedicine. 2007; 1(4):473-81. PMC: 2676641. DOI: 10.2147/nano.2006.1.4.473. View

5.
Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, Trajanoski Z . CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res. 2006; 34(Web Server issue):W498-503. PMC: 1538903. DOI: 10.1093/nar/gkl038. View